Figure Gallery

Expression Pattern Search Results for myb

(247 figures with expression from 126 publications)
Publication	Data	Fish	Condition	Stage Range	Anatomy
Esain et al., 2015	Fig. 7	WT WT + MO1-selp WT + MO1-selplg	control chemical treatment: cannabinoid receptor agonist	Day 4	thymus
	Fig. 2	WT	control chemical treatment: cannabinoid receptor agonist chemical treatment: cannabinoid receptor agonist	Prim-25	intermediate cell mass of mesoderm
	Fig. 3	WT	control chemical treatment: cannabinoid receptor agonist chemical treatment: cannabinoid receptor agonist	Day 4	head kidney hematopoietic system posterior region thymus
	Fig. 5	WT	control chemical treatment: cannabinoid receptor agonist, chemical treatment: NS-398 chemical treatment: cannabinoid receptor agonist, chemical treatment: EC 2.7.11.* (protein-serine/threonine kinase) inhibitor chemical treatment: EC 2.7.11.* (protein-serine/threonine kinase) inhibitor chemical treatment: NS-398 chemical treatment: cannabinoid receptor agonist	Prim-25	intermediate cell mass of mesoderm
Gao et al., 2015	Fig. 1	WT topbp1^{cas003/cas003}	control	Day 5	hematopoietic system posterior side kidney thymus
	Fig. 2	WT topbp1^{cas003/cas003}	control	Prim-25 to Day 4	hematopoietic multipotent progenitor cell
	Fig. 3	TU WT topbp1^{cas003/cas003} TU + MO2-topbp1	control	Protruding-mouth to Day 5	hematopoietic system posterior side
	Fig. 4	WT topbp1^{cas003/cas003}	control	Protruding-mouth	hematopoietic multipotent progenitor cell
	Fig. 5	WT topbp1^{cas003/cas003} topbp1^{cas003/cas003}; tp53^zdf1/+ topbp1^{cas003/cas003}; tp53^zdf1/zdf1	control	Day 4	hematopoietic multipotent progenitor cell hematopoietic system posterior side
	Fig. 7	WT topbp1^{cas003/cas003}	control chemical treatment: hydroxyurea	Protruding-mouth	hematopoietic multipotent progenitor cell
Jia et al., 2015	Fig. 5	kri1^{cas002/cas002} kri1^{cas002/cas002} + MO2-becn1	standard conditions	Protruding-mouth	post-vent region hematopoietic stem cell
	Fig. S12	WT WT + MO7-tp53 kri1^{cas002/cas002} + MO7-tp53	standard conditions control	Protruding-mouth	post-vent region hematopoietic stem cell
	Fig. 1	WT kri1^{cas002/cas002}	standard conditions control	Protruding-mouth to Day 5	head kidney post-vent region hematopoietic stem cell thymus
	Fig. S4	WT kri1^{cas002/cas002}	standard conditions control	Prim-25 to Day 4	post-vent region hematopoietic stem cell ventral wall of dorsal aorta
	Fig. S13	tp53^zdf1/zdf1 tp53^zdf1/zdf1 + MO1-kri1 tp53^zdf1/zdf1 + MO2-kri1	standard conditions	Protruding-mouth	post-vent region hematopoietic stem cell
	Fig. 2	WT WT + MO1-kri1 WT + MO2-kri1	standard conditions control	Protruding-mouth	post-vent region hematopoietic stem cell
Li et al., 2015	Fig. 3	WT tet2^mk17/mk17; tet3^mk18/mk18	standard conditions	Prim-25	dorsal aorta hematopoietic stem cell
Lin et al., 2015	Fig. 1	WT cz3328Tg	control heat shock	Prim-25 to Day 4	head kidney hematopoietic multipotent progenitor cell hematopoietic multipotent progenitor cell ventral wall of dorsal aorta hematopoietic multipotent progenitor cell
	Fig. 2	WT cz3328Tg kca3Tg; kca4Tg WT + MO1-angptl1a + MO2-angptl2b mib1^ta52b/ta52b; cz3328Tg kca3Tg; kca4Tg + MO1-angptl1a + MO2-angptl2b	heat shock	Prim-25	ventral wall of dorsal aorta hematopoietic multipotent progenitor cell
	Fig. 4	WT WT + MO1-mycb	control	Prim-25	ventral wall of dorsal aorta hematopoietic multipotent progenitor cell
Liu et al., 2015	Fig. 6	TU cebpa^rj31/rj31 dnmt1^rj794/rj794 (TU) dnmt1^rj794/rj794; cebpa^rj31/rj31	control	Protruding-mouth	caudal hematopoietic tissue hematopoietic stem cell
	Fig. 1	TU dnmt1^rj794/rj794 (TU)	control	Prim-25 to Day 5	hematopoietic stem cell
	Fig. 3	TU WT dnmt1^rj794/rj794 (TU) WT + MO4-dnmt1 WT + MO7-dnmt1	control	Prim-25 to Day 5	hematopoietic stem cell
	Fig. 5	TU WT dnmt1^rj794/rj794 (TU) WT + MO4-dnmt1	control	Prim-25 to Day 5	hematopoietic stem cell
Lu et al., 2015	Fig. 2	WT mir142a^ioz13/ioz13	standard conditions	Long-pec to Protruding-mouth	hematopoietic multipotent progenitor cell